Enhanced intestinal absorption of salmon calcitonin (sCT) from proliposomes containing bile salts

被引:126
作者
Song, KH [1 ]
Chung, SJ [1 ]
Shim, CK [1 ]
机构
[1] Seoul Natl Univ, Coll Pharm, Dept Pharmaceut, Seoul 151742, South Korea
关键词
salmon calcitonin; caco-2 cell monolayer; bile salts; ion-pair complex; proliposomes; bioavailability;
D O I
10.1016/j.jconrel.2005.05.016
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose: The feasibility of using proliposomes containing salmon calcitonin (sCT) and absorption enhancing agents, as an oral delivery system, to improve the intestinal absorption of sCT was explored using rats and Caco-2 cell systems. Methods: Seventeen surfactants were examined for their effects with reference to accelerating the permeability of sCT (300 mu g/ ml) across Caco-2 cell monolayers, and damage to the intestinal epithelial cells, as measured by the change in transepithelial electrical resistance (TEER) across the cell monolayer. Proliposomes containing sCT (0.75%, w/w) and sodium taurodeoxycholate (NaTDC, 2.5%, w/w) (TDC proliposomes) were prepared according to the standard method using sorbitol and phosphatidylcholine as core and wall-forming materials, respectively, administered intra-duodenally to rats, and plasma concentrations of sCT were subsequently determined by LC-MS. Results: Among the surfactants examined, some bile salts including NaTDC appeared to be the most advantageous when estimated based on the balance between the permeation enhancement (e.g., a 10.8-fold increase in the permeability of sCT for 0.1% NaTDC) and damage to the cells (e.g., a 3.55-fold decrease in the TEER value for 0.1% NaTDC). The administration of TDC proliposomes resulted in a 7.1-fold increase in the bioavailability (i.e., 0.49%) of sCT, when administered duodenally to rats. The size of the reconstituted liposomes in water was significantly smaller (e.g., 23.2 nm, number weighted diameter), and the entrapment efficiency (EE) of sCT in the reconstituted liposomes was 2.8-fold larger (54.9%), for TDC proliposomes, compared to proliposomes prepared without NaTDC (sCT proliposomes). Conclusion: A 7.1-fold increase in the bioavailability of sCT could be achieved from the TDC proliposomes. In addition to the intrinsic activity of the bile salt to fluidize the membrane, the simultaneous delivery of sCT and NaTDC to the site of absorption in the intestine via proliposomes and the subsequent formation of lipophilic ion-pair complexes between sCT and NaTDC at the site might have been contributing factors in this outstanding absorption enhancement. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:298 / 308
页数:11
相关论文
共 26 条
[1]   CORRELATION BETWEEN ORAL-DRUG ABSORPTION IN HUMANS AND APPARENT DRUG PERMEABILITY COEFFICIENTS IN HUMAN INTESTINAL EPITHELIAL (CACO-2) CELLS [J].
ARTURSSON, P ;
KARLSSON, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 175 (03) :880-885
[2]   EVIDENCE FOR A POLARIZED EFFLUX SYSTEM IN CACO-2 CELLS CAPABLE OF MODULATING CYCLOSPORINE-A TRANSPORT [J].
AUGUSTIJNS, PF ;
BRADSHAW, TP ;
GAN, LSL ;
HENDREN, RW ;
THAKKER, DR .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 197 (02) :360-365
[3]  
Florence AT, 1993, PHARM PARTICULATE CA, P65
[4]   Improvement of intestinal absorption of human calcitonin by chemical modification with fatty acids: Synergistic effects of acylation and absorption enhancers [J].
Fujita, T ;
Fujita, T ;
Morikawa, K ;
Tanaka, H ;
Iemura, O ;
Yamamoto, A ;
Muranishi, S .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 134 (1-2) :47-57
[5]  
GELDER JV, 1999, INT J PHARM, V186, P127
[6]   Intranasal insulin delivery and therapy [J].
Hinchcliffe, M ;
Illum, L .
ADVANCED DRUG DELIVERY REVIEWS, 1999, 35 (2-3) :199-234
[7]  
KARARLI TT, 1989, CRIT REV THER DRUG, V6, P39
[8]   Regional oral absorption, hepatic first-pass effect, and non-linear disposition of salmon calcitonin in beagle dogs [J].
Lee, YH ;
Leesman, GD ;
Makhey, V ;
Yu, HS ;
Hu, PD ;
Perry, B ;
Sutyak, JP ;
Wagner, EJ ;
Falzone, LM ;
Stern, W ;
Sinko, PJ .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2000, 50 (02) :205-211
[9]  
MURANISHI S, 1990, CRIT REV THER DRUG, V7, P1
[10]   ION-PAIR TRANSPORT ACROSS MEMBRANES [J].
NEUBERT, R .
PHARMACEUTICAL RESEARCH, 1989, 6 (09) :743-747